癌症研究
上睑下垂
肿瘤微环境
免疫系统
免疫疗法
光动力疗法
三阴性乳腺癌
免疫原性细胞死亡
医学
化学
癌症
免疫学
乳腺癌
炎症
内科学
炎症体
有机化学
作者
Jianquan Yang,Wen Guo,Rong Huang,Jiaojiao Bian,Siqi Zhang,Ting Wei,Chuanshi He,Ziyue Hu,Juan Li,Chunyang Zhou,Man Lu
标识
DOI:10.3389/fimmu.2023.1173487
摘要
Triple-negative breast cancer (TNBC) is characterized by a high degree of malignancy, early metastasis, limited treatment, and poor prognosis. Immunotherapy, as a new and most promising treatment for cancer, has limited efficacy in TNBC because of the immunosuppressive tumor microenvironment (TME). Inducing pyroptosis and activating the cyclic guanosine monophosphate-adenosine monophosphate synthase/interferon gene stimulator (cGAS/STING) signaling pathway to upregulate innate immunity have become an emerging strategy for enhancing tumor immunotherapy. In this study, albumin nanospheres were constructed with photosensitizer-IR780 encapsulated in the core and cGAS–STING agonists/H 2 S producer-ZnS loaded on the shell (named IR780-ZnS@HSA). In vitro , IR780-ZnS@HSA produced photothermal therapy (PTT) and photodynamic therapy (PDT) effects. In addition, it stimulated immunogenic cell death (ICD) and activated pyroptosis in tumor cells via the caspase-3–GSDME signaling pathway. IR780-ZnS@HSA also activated the cGAS–STING signaling pathway. The two pathways synergistically boost immune response. In vivo , IR780-ZnS@HSA + laser significantly inhibited tumor growth in 4T1 tumor-bearing mice and triggered an immune response, improving the efficacy of the anti-APD-L1 antibody (aPD-L1). In conclusion, IR780-ZnS@HSA, as a novel inducer of pyroptosis, can significantly inhibit tumor growth and improve the efficacy of aPD-L1.
科研通智能强力驱动
Strongly Powered by AbleSci AI